Nucleos(t)ide analogues in patients with chronic hepatitis B: to stop or not to stop?

被引：5

作者：

Kao, Jia--Horng ^{[1
]}

Berg, Thomas ^{[2
]}

机构：

[1] Natl Taiwan Univ Coll Med & Hosp, Grad Inst Clin Med, Taipei, Taiwan

[2] Univ Hosp Leipzig, Clin & Polyclin Gastroenterol Hepatol Infectiol &, Liebigstr 20, Leipzig, Germany

来源：

GUT | 2019年 / 68卷 / 12期

关键词：

THERAPY;

D O I：

10.1136/gutjnl-2019-319648

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：2105 / 2106

页数：2

共 13 条

[1] Long-term response after stopping tenofovir disoproxil fumarate in non-cirrhotic HBeAg-negative patients - FINITE study [J].

Berg, Thomas ;

Simon, Karl-Georg ;

Mauss, Stefan ;

Schott, Eckart ;

Heyne, Renate ;

Klass, Dietmar M. ;

Eisenbach, Christoph ;

Welzel, Tania Mara ;

Zachoval, Reinhart ;

Felten, Gisela ;

Schulze-zur-Wiesch, Julian ;

Cornberg, Markus ;

Op den Brouw, Marjoleine L. ;

Jump, Belinda ;

Reiser, Hans ;

Gallo, Lothar ;

Warger, Tobias ;

Petersen, Joerg .

JOURNAL OF HEPATOLOGY, 2017, 67 (05) :918-924

[2] Systematic review: cessation of long-term nucleos(t)ide analogue therapy in patients with hepatitis B e antigen-negative chronic hepatitis B [J].

Chang, M. -L. ;

Liaw, Y. -F. ;

Hadziyannis, S. J. .

ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 42 (03) :243-257

[3] EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [J].

Lampertico P. ;

Agarwal K. ;

Berg T. ;

Buti M. ;

Janssen H.L.A. ;

Papatheodoridis G. ;

Zoulim F. ;

Tacke F. .

JOURNAL OF HEPATOLOGY, 2017, 67 (02) :370-398

[4] Role of HBsAg Testing in the Management of Patients with Chronic HBV [J].

Hong T.-C. ;

Yang H.-C. ;

Kao J.-H. .

Current Hepatology Reports, 2019, 18 (3) :331-341

[5] Incidence and predictors of hepatitis B surface antigen seroclearance after cessation of nucleos(t)ide analogue therapy in hepatitis B e antigen-negative chronic hepatitis B [J].

Jeng, Wen-Juei ;

Chen, Yi-Cheng ;

Chien, Rong-Nan ;

Sheen, I-Shyan ;

Liaw, Yun-Fan .

HEPATOLOGY, 2018, 68 (02) :425-434

[6] Less can be more: A finite treatment approach for HBeAg-negative chronic hepatitis B [J].

Lampertico, Pietro ;

Berg, Thomas .

HEPATOLOGY, 2018, 68 (02) :397-400

[7]

Lang S, 2020, HEPATOLOGY, V71, P522, DOI [10.1002/hep.30832/suppinfo, 10.1002/hep.30832]

[8] Limited sustained response after stopping nucleos(t)ide analogues in patients with chronic hepatitis B: results from a randomised controlled trial (Toronto STOP study) [J].

Liem, Kin Seng ;

Fung, Scott ;

Wong, David K. ;

Yim, Colina ;

Noureldin, Seham ;

Chen, Jiayun ;

Feld, Jordan J. ;

Hansen, Bettina E. ;

Janssen, Harry L. A. .

GUT, 2019, 68 (12) :2206-2213

[9] New perspectives of biomarkers for the management of chronic hepatitis B [J].

Lin, Chih-Lin ;

Kao, Jia-Horng .

CLINICAL AND MOLECULAR HEPATOLOGY, 2016, 22 (04) :423-431

[10] Discontinuation of oral antivirals in chronic hepatitis B: A systematic review [J].

Papatheodoridis, George ;

Vlachogiannakos, Ioannis ;

Cholongitas, Evangelos ;

Wursthorn, Karsten ;

Thomadakis, Christos ;

Touloumi, Giota ;

Petersen, Joerg .

HEPATOLOGY, 2016, 63 (05) :1481-1492

← 1 2 →